Therefore, we characterized INPP4B and PTEN expression levels, as well as PI3K/Akt (phosphoS473 Akt) and MAPK pathway (phospho-p42/44) activation in ten different human ovarian cancer cell lines (Supplemental Figure 5C). This evidence concerns the gene AKT1 and ovarian carcinoma.